Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.89
Bid: 0.86
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.06 (6.977%)
Open: 0.89
High: 0.89
Low: 0.89
Prev. Close: 0.89
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

13 Aug 2009 08:30

RNS Number : 3763X
J.P. Morgan Private Equity Ltd
13 August 2009
 



J.P. Morgan Private Equity Exceeds Fundraising Target 

 * * *

GUERNSEY13 AUGUST 2009 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company"), the London Stock Exchange listed private equity secondary fundannounces that it has exceeded the Company's initial fundraising target by over 50% Through a series of closings in July and August, JPEL has raised over $75 million.   

"We believe that the overwhelming support for the fundraising from our existing shareholders and new JPEL investors is a vote of confidence for opportunities available in the secondary private equity market," said JPEL Chairman Trevor Ash. "Most of this capital was raised at a premium to the stock price while the JPEL share price rebounded by 30.6% in the quarter ending June 30thfurther demonstrating the market's faith in our strategy." 

"We started meeting with existing and potential new shareholders in June, with an initial fundraising target of $50 million. With current funds raised at over $75 million, JPEL has received a strong response from investors." said Gregory Getschow, JPEL's portfolio manager. "We now have significant fresh capital to invest, and intend to use it in a way to drive NAV growth."

"We look forward to investing in what we hope to be accretive secondary investments that generate value for our shareholders." commented Troy Duncan, JPEL's portfolio manager. "We believe that the current market for secondary private equity investments represents a significant opportunity for JPEL to deploy capital at favourable valuations."

JPEL closed at $1.01 per US$ Equity Share on 11 August 2009representing 24.6discount to 30 June 2009 NAV, approximately 25 percentage points narrower than the average discount of 50% experienced by its peer group of listed private equity fund of funds.

JPEL's primary strategy is to acquire secondary market portfolios of direct fund investments, significantly invested partnership interests and partially drawn commitments, in order to accelerate NAV development. JPEL employs an opportunistic, deep value private equity investment strategy and focuses on value-oriented investments with potential for early return of capital. From inception through 30 June 2009, JPEL's NAV per US$ Equity Share has grown 31.4% from $1.02 at inception versus declines of 22.8%, 16.1% and 58.3% in the S&P 500, MSCI World Index (USD)  and LPX indices, respectively.

The Company has also announced that it will issue warrants free of subscription cost to shareholders on record as at 17 August 2009. One warrant will be issued for every six US$ Equity Shares owned. The warrants will be publicly traded on the London Stock Exchange, subject to all regulatory approvals and the strike price will be based on the Company's unaudited estimated 30 June 2009 NAV per US$ Equity Share plus a premium.

 * * *

  

About J.P. Morgan Private Equity Limited 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.  The Company's capital structure consists of three classes of shares: Equity Shares and two classes of Zero Dividend Preference Shares due 2013 and 2015, respectively.

Applications have been made to the UK Listing Authority for the Warrants to be admitted to the Official List and to the London Stock Exchange for the Warrants to be admitted to trading on its main market under the symbol "JPWW".

J.P. Morgan Private Equity Limited

Troy Duncan / Gregory Getschow

Telephone: +44 (0) 20 7742 3032 / +1 212 648 1150

Peregrine Communications

Anthony Payne / Paul Mungo

Telephone: +44 (0) 20 3178 6869 / +44 (0)20 7822 2307

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOECKNKBOBKKOFD
Date   Source Headline
15th Nov 20195:52 pmRNSNet Asset Value(s) - September
15th Nov 20195:51 pmRNSNet Asset Value(s) - August 2019
15th Nov 20195:51 pmRNSNet Asset Value(s) - July 2019
5th Nov 20195:42 pmRNS2019 AGM CIRCULAR
22nd Oct 20197:00 amRNSCompletion of Sixth Mandatory Redemption
9th Oct 20193:28 pmRNSSixth Mandatory Redemption
27th Sep 201910:48 amRNSAnnual Financial Report - 30 June 2019
10th Sep 20191:19 pmRNSNet Asset Value(s) - June 2019
12th Jul 20197:00 amRNSNet Asset Value(s) - May 2019
13th Jun 20197:00 amRNSNet Asset Value(s) - April 2019
17th May 20197:00 amRNSNet Asset Value(s) - March 2019
5th Apr 20197:00 amRNSNet Asset Value(s) - February 2019
19th Mar 20193:57 pmRNSHalf-year Report - 31 December 2018
13th Mar 20197:00 amRNSNet Asset Value(s)
7th Feb 201910:55 amRNSNet Asset Value(s) - December 2018
22nd Jan 201910:10 amRNSNet Asset Value(s) - November 2018
8th Jan 20197:00 amRNSCompletion Of Fifth Mandatory Redemption
10th Dec 20183:58 pmRNSMandatory Redemption - US$Equity Shares - Dec 2018
6th Dec 20183:28 pmRNSHolding(s) in Company
30th Nov 20183:21 pmRNSNet Asset Value(s) - October 2018
27th Nov 201811:08 amRNSAGM Results 2018
7th Nov 20187:00 amRNS2018 AGM CIRCULAR
30th Oct 20187:00 amRNSNet Asset Value(s) - August 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - September 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - July 2018
12th Oct 20184:32 pmRNSHolding(s) in Company
4th Oct 20182:42 pmRNSNotification of Dealings in Shares
28th Sep 20181:10 pmRNSAnnual Financial Report - 30 June 2018
17th Sep 20187:00 amRNSNet Asset Value(s) - June 2018
22nd Aug 20185:11 pmRNSHolding(s) in Company
20th Jul 20187:00 amRNSNet Asset Value(s) - May 2018
3rd Jul 20187:00 amRNSNet Asset Value(s) - April 2018
9th May 20187:00 amRNSNet Asset Value(s) - March 2018
13th Apr 20189:30 amRNSNet Asset Value(s) - February 2018
11th Apr 20187:00 amRNSNotice to Shareholders - Total Voting Rights
10th Apr 20182:24 pmRNSCompletion of Fourth Mandatory Redemption
22nd Mar 20187:00 amRNSHalf-year Report - 31 December 2017
22nd Mar 20187:00 amRNSMandatory Redemption- US$Equity Shares -April 2018
12th Mar 20187:00 amRNSNet Asset Value(s) - January 2018
2nd Feb 20187:00 amRNSNet Asset Value(s) - December 2017
15th Jan 20187:00 amRNSNet Asset Value(s) - November 2017
29th Dec 20171:15 pmRNSNotice to Shareholders - Key Information Document
14th Dec 20175:50 pmRNSNotice to Shareholders - Total Voting Rights
14th Dec 20177:00 amRNSCompletion Of Third Mandatory Redemption
4th Dec 20172:52 pmRNSAGM Results
4th Dec 20179:44 amRNSNet Asset Value(s) - October 2017 Review
1st Dec 20177:05 amRNSMandatory Redemption - US$Equity Shares - Dec 2017
1st Dec 20177:00 amRNSNet Asset Value(s) - October 2017
24th Nov 20177:00 amRNSSale of Celerion
20th Nov 20172:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.